The 8 analysts offering 12-month price forecasts for Cellectis SA have a median target of 8.50, with a high estimate of 14.00 and a low estimate of 3.00. The median estimate represents a +394.19% increase from the last price of 1.72.
The current consensus among 9 polled investment analysts is to Buy stock in Cellectis SA. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.38
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.